Table of Contents      
SHORT COMMUNICATION
Year : 2015  |  Volume : 7  |  Issue : 2  |  Page : 165-167

Trigeminal neuralgia: An overview of the clinical entity


1 Department of Orthodontics, Institute of Dental Sciences, Sehoora, Jammu, India
2 Department of Anesthesiology and Pain Medicine, Sheri Kashmir Institute of Medical Sciences, Soura, Srinagar, India
3 Department of Anesthesiology and Pain Medicine, Division of Neuroanesthesiology, Sheri Kashmir Institute of Medical Sciences, Soura, Srinagar, India

Date of Web Publication3-Sep-2015

Correspondence Address:
Zulfiqar Ali
Division of Neuroanesthesiology, Department of Anesthesiology and Pain Medicine, Sheri Kashmir Institute of Medical Sciences, Soura, Srinagar
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2231-0754.164404

Rights and Permissions
   Abstract 

Trigeminal neuralgia (TN) is a rare neurological disease that causes sudden, severe, brief, stabbing recurrent episodes of facial pain in one or more branches of the trigeminal nerve. Over the last few decades, there is evidence that TN may be a result of compression of the trigeminal nerve root at or near the dorsal root entry zone by a blood vessel. TN is treated on an outpatient basis, unless neurosurgical intervention is required. Treatment can be subdivided into pharmacologic therapy, percutaneous procedures, surgery, and radiosurgery. Medical therapy is often sufficient and effective, allowing surgical consideration only if pharmacological treatment fails. Medical therapy alone is an adequate treatment for 75% of patients.

Keywords: Management, pathogenesis, trigeminal neuralgia


How to cite this article:
Qayoom N, Syed S, Ali Z, Khan T. Trigeminal neuralgia: An overview of the clinical entity. J Int Clin Dent Res Organ 2015;7:165-7

How to cite this URL:
Qayoom N, Syed S, Ali Z, Khan T. Trigeminal neuralgia: An overview of the clinical entity. J Int Clin Dent Res Organ [serial online] 2015 [cited 2017 Sep 21];7:165-7. Available from: http://www.jicdro.org/text.asp?2015/7/2/165/164404


   Introduction Top


The main sensory trigeminal pathway processes discriminative touch and proprioceptive information from the face. There are three sensory nuclei; mesencephalic nucleus, main sensory nucleus, and spinal nucleus arranged in a column from midbrain through the pons and medulla and into the upper cervical cord. International Association for the Study of Pain (IASP) defines trigeminal neuralgia (TN) as a sudden, usually unilateral, severe brief stabbing recurrent pain in distribution of one or more branches of the fifth cranial nerve. [1] TN mostly involves the maxillary or them andibular branch, though all the three branches of the nerve may be affected. Typically, brief attacks are triggered by talking, chewing, tooth brushing, shaving, a light touch, or even a cool breeze on a very localized spot on the face (the so-called "trigger zone"). The trigger zones are most commonly located on cheek, medial and lateral aspect of eyebrows, nose, lip, and buccal mucosa. Minimal stimulation in these areas initiates a painful attack. Patients with TN can pinpoint these areas and will assiduously avoid any stimulation of them. Not all patients with TN have trigger zones, but trigger zones are nearly pathognomonic for this disorder. [2] The pain is abrupt in onset and termination and may remit for varying periods. The International Headache Society, [3] made a distinction between classical and symptomatic TN (CTN and STN): CTN includes all cases without an established etiology, i.e. idiopathic, as well as those with potential vascular compression of the fifth cranial nerve, whereas the diagnosis of STN is made in cases secondary to tumor, multiple sclerosis (MS), structural abnormalities of the skull base, and the like.


   Etiology of TN Top


Several causes of TN include compression of trigeminal sensory root by the bony irregularities along petrous temporal ridge, compression of the nerve near the pons by arterial loops, tumors, or irritation by sclerotic plaques. TN may be a result of compression of trigeminal nerve root near the dorsal root entry zone by a blood vessel. This compression may be related to an aberrant branch of the superior cerebellar artery that lies on the trigeminal nerve. Surgical decompression of the nerve has led to a long term pain relief in these patients.

Multiple sclerosis is seen in 2-4% of patients with TN. These patients are younger with bilateral neuralgias. Tumors, usually posterior fossa meningiomas or neuromas, are present in around 2% of patients.


   Investigations Top


No specific tests exist for the diagnosis of TN. A clinical examination with assessment of the cranial nerve function is helpful to rule out multiple sclerosis and tumors. If there is a cranial nerve dysfunction or a facial sensory loss, it should be followed by cerebral imaging. Imaging of the relationship of the nerves and the blood vessels in its vicinity is done by magnetic resonance tomographic angiography (MRTA). Though arteries are easily visualized, veins are seen after enhancement with intravenous gadolinium. A three-dimensional constructive interference in steady state (3D-CISS) is useful in delineating the pathology.


   Treatment Top


Microvascular decompression

A suboccipital craniotomy is done. After retracting the cerebellum, a segment of the superior cerebellar artery compressing the nerve at the root entry zone may be seen. Sometimes the anterior inferior cerebellar artery or superior petrosal veins is compressing the nerve. A piece of shredded Teflon is placed between the vessel and the nerve to separate them. From the group of patients with typical TN followed over median follow-up of 9.7 years, 82% had good long-term results after operation. [4]

Radiofrequency gangliolysis

The procedure is carried out under fluoroscopy with radiofrequency needle through the foramen ovale into Meckel's cave. A stepwise advancement of needle will stimulate in succession the third, second, and first divisions of the trigeminal nerve. On entering the Meckel's cave, aspiration will yield cerebrospinal fluid. Stimulation of the affected nerve is followed by lesioning of the affected division. Immediate pain relief is high; but after a period of around 3 years, one-third of the patients reported recurrent neuralgia.

Glycerol rhizolysis

The needle is inserted under fluoroscopy through the foramen ovale into trigeminal cistern. Sterile anhydrous glycerol up to 0.1-0.4 ml is injected. After 12 months, recurrence may be as high as 10-53%. Complications such as meningitis, cranial nerve palsies, and local hematomas can occur.

Balloon compression

Under fluoroscopic control, a guide needle is inserted into the foramen ovale. A Fogarty catheter is passed through till its tip reaches the Meckel's cave; and after this, balloon is inflated with 0.5-1.0 ml of contrast causing adequate compression. Masseter weakness, due to compression of motor branch, may result which recovers over several weeks.

Stereotactic radiosurgery

A stereotactic frame is fixed to the patient's head. After fixation, the patient is taken for magnetic resonance imaging. Trigeminal nerve is identified on imaging. Radiosurgery is carried out in the supine position. Pain relief is not immediate and occurs after 1 month.

Peripheral neurectomy

Peripheral neurectomy is done by maxillofacial surgeons with remarkable pain relief lasting for 1-5 years in 75% of patients. Ali et al., [5] observed that postsurgical pain relief varied from 15 to 24 months in cases where neurectomy was done without placing stainless steel screws in the foramina.

Neurectomies may be done through an incision made at the eyebrow (supraorbital nerve) or intraorally (infraorbital, alveolar, and lingual nerves). The neural branches are divided and avulsed with blocking of the foramina by bone wax. Peripheral neurectomies do not appear to offer any advantages over other surgical procedures.

Cryotherapy

In cryotherapy, a peripheral branch of the three major divisions of the trigeminal nerve is frozen by a cryoprobe ata temperature of -50 to -70°C.

Alcohol block

Alcohol injections are given directly into the nerve. There is a high risk of recurrence of pain. However, they are used because of their simplicity in elderly and frail patients.

Pharmacotherapy

Pharmacological therapy is main stay of treatment of TN. Carbamazepine is the gold standard drug. When compared with placebo in several studies, there was a good clinical response in around 70% of patients. The other drugs commonly used for TN are oxcarbazepine, phenytoin, lamotrigine, baclofen, tizanidine, pimozide, and tocainade. Currently, there is no published data showing the advantage of polytherapy over monotherapy for the treatment of TN. The American Academy of Neurology (AAN) and the European Federation of Neurological Society (EFNS) [6] recommends the use of carbamazepine oroxcarbazepine as the first choice for pharmacological treatment ofCTN, and baclofen or lamotrigine as second choice.


   Which Treatment to Choose First? Top


The choice of treatment in TN may be influenced by expertise and available gadgets.

There is currently no available literature showing superiority of surgical treatment over gangliolysis. The patient should be informed about all the treatment options available. The AAN and the EFNS [6] summarize that the percutaneous Gasserian lesions can be safely performed in the elderly but often engender facial numbness. Microvascular decompression provides long-lasting pain relief, but involves some risk of major neurological complications. Gamma-knife is the least invasive and safest procedure, but pain relief may take 1month to develop. A Cochrane review [7] concluded that there is a very low quality evidence for the efficacy of most neurosurgical procedures for TN because of the poor quality of trials. All procedures produce variable pain relief, but many result in sensory side effects. There is little evidence to help comparative decision making about the best surgical procedure. Well-designed studies are urgently needed.

 
   References Top

1.
Merskey H, Bogduk N. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms, 2 nd edition. Seattle: IASP Press; 1994. p. 59-71  Back to cited text no. 1
    
2.
Krafft RM. Trigeminal neuralgia. Am Fam Physician 2008;77:1291-6.  Back to cited text no. 2
    
3.
Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2 nd edition. Cephalalgia 2004;24:9-160.  Back to cited text no. 3
[PUBMED]    
4.
Oesman C, Mooij JJ. Long-term follow-up of microvascular decompression for trigeminal neuralgia. Skull Base 2011; 21:313-22.  Back to cited text no. 4
[PUBMED]    
5.
Ali FM, Prasant M, Pai D, Aher VA, Kar S, Safiya T. Peripheral neurectomies: A treatment option for trigeminal neuralgia in rural practice. J Neurosci Rural Pract 2012;3:152-7.  Back to cited text no. 5
[PUBMED]  Medknow Journal  
6.
Cruccu G, Gronseth G, Alksne J, Argoff C, Brainin M, Burchiel K, et al. American Academy of Neurology Society. European Federation of Neurological Society. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 2008;15:1013-28.  Back to cited text no. 6
    
7.
Zakrzewska JM, Akram H. Neurosurgical interventions for the treatment of classical trigeminal neuralgia. Cochrane Database Syst Rev 2011;9.  Back to cited text no. 7
    




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
   Introduction
   Etiology of TN
   Investigations
   Treatment
    Which Treatment ...
    References

 Article Access Statistics
    Viewed513    
    Printed6    
    Emailed0    
    PDF Downloaded47    
    Comments [Add]    

Recommend this journal